Promotion of community health careis one of the major health and treatment policies. In this regard, prevention is considered the primary, most important and effective level of health care. Given the high prevalence of congenital (sensorineural) hearing loss (nearly 1/1000 to 3/1000 of live births) large numbers of neonates with congenital hearing loss will be born annually. Hearing loss will cause adverse effects on social, cognitive and speech development of these children. Therefore, early, even neonatal, diagnosis and treatment of hearing loss has been recommended in order to prevent such complications. This study has been conducted with the aim of hearing screening of the newborns and evaluating the effective factors on Auditory Brainstem Response (ABR) test. In this descriptive study all included newborns were examined by TEOAE test during first week after birth. The result of the test was interpreted as "Pass" or "Refer". In case of "Refer", the test was repeated 3 weeks later. In neonates with the test result of "refer" in the second step, the ABR was done.The following risk factors were evaluated: 1) History of NICU admission for more than 48 hours 2) History of neonatal exchange transfusion 3) Family history of hearing deficiency 4) Birth weight 5) Administration of aminoglycosides in neonatal period. Of the total5850 evaluated newborns, 5148 (88%) gained criteria of "Pass" in first step of the test, while 702 cases (12%) were "Referred" to the second step and 468(8%) had impaired ABRtest. Related risk factors were evaluated in neonates with the abnormal OAE test or in those with the result of "Refer". This showed that: 1) History of NICU admission for more than 48 hours was positive in 4.8% of normal newborns but in 55% of neonates with abnormal ABR test, and the difference was significant (P<0.001). 2) Family history of hearing deficiency was positive in 4.4% of normal newborns but 5.9% of neonates with abnormal ABR test, so there was not a significant relation (P=0.191). 3) Low birth weight (<1500 gr) was found in 1.5% of normal newborns and 11.5% of neonates with abnormal ABR test, and the relation was statistically significant (P<0.001). 4) History of neonatal exchange transfusion was present in 2.8% of normal newborns but 2.1% of neonates with abnormal ABR test, so there was not a significant relation (P=0.563) 5) Administration of aminoglycosides in neonatal period was present in 2% of normal newborns but20% neonates with abnormal ABR test, which were significantly different (P<0.001).The results showed a significant relation between abnormal ABR test and history of NICU admission for more than 48 hours, low birth weightand administration of aminoglycosides in neonatal period. Because of high prevalence of congenital hearing loss and it's adverse effects on child development, screening of hearing sense is recommend as soon as clinically possible after birth. In addition, paying attention to the related risk factors and particular focus on neonates with such risk factors seems beneficial. Among th...
Background and Aim: Although cochlear implantation (CI) is a safe surgical procedure for severe to profound sensorineural hearing loss (SNHL) but, due to the embryological and anatomical connection between the vestibular and cochlear structures, vestibular dysfunction may occur after CI. Video head impulse test (vHIT) is a reliable test for assessing the function of semicircular canals (SCCs). This study aimed to determine the early effect of CI on SCCs function, by comparing pre- and post-operative vHIT results. Methods: In this cross-sectional study, participants were 22 adults with SNHL scheduled for unilateral CI in the right ear and 22 age-matched healthy subjects as a control group. The vHIT was conducted before and two weeks after CI. Results: The mean vHIT gains in the SNHL group were significantly lower than in controls, with a large effect size. Furthermore, the mean vHIT gains in the right lateral SCCs (p<0.001) and right anterior SCCs (p=0.003) were significantly reduced after CI, compared to the gain values before CI, with a large pooled effect size. However, these differences were not statistically significant for the right posterior SCCs. The comparison of vHIT gains in the non- implanted ear showed no statistically significant difference between pre- and post-operative phases. Conclusion: The vHIT is a useful clinical method to detect the early effects of CI on the function of SCCs. These effects are more obvious in the lateral and superior SCCs in the implanted ear. Keywords: Cochlear implantation; semicircular canals; video head impulse test
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.